Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study

19 Aug 2024

Abstract excerpt

Tumor-derived exosomes are involved in tumor progression and immune invasion and might function as promising noninvasive approaches for clinical management. However, there are few reports on exosom-based markers for predicting the progression and adjuvant therapy response rate among patients with clear cell renal cell carcinoma (ccRCC). The signatures differentially expressed in exosomes from tumor and normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39735439
DOI: 10.1016/j.jncc.2024.07.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort studyPMID 39735439Read ↗

Establishment of a Seven-Gene Signature Associated with CD8+ T Cells through the Utilization of Both Single-Cell and Bulk RNA-Sequencing Techniques in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinomaSemantic proximity Read ↗

Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinomaSemantic proximity Read ↗

Ferroptosis-related lncRNA signature robustly predicts the prognosis and immunotherapy efficiency of clear cell renal cell carcinomaSemantic proximity Read ↗

Machine Learning-Driven Prognostic Analysis of Cuproptosis and Disulfidptosis-related lncRNAs in Clear Cell Renal Cell Carcinoma: A Step Towards Precision OncologySemantic proximity Read ↗

Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinomaSemantic proximity Read ↗

Novel Prognosis and Therapeutic response model of Immune-related lncRNA pairs in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Multi-omics features-based machine learning method improve immunotherapy response in clear cell renal cell carcinomaSemantic proximity Read ↗

Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular trapsSemantic proximity Read ↗

A Novel Prognostic Model for Clear Cell Renal Cell Carcinoma with Differentially Expressed Immune-related lncRNA Pairs Based on the Cancer Genome AtlasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.